That soon to be announced deal is an immediate revenue generator,well at least according to Alan.
Will this be the week stock pops to 4.00+? Quite possibly..
Biodel is not Big Pharma but if this product does get approval in a year or 2 ,Biodel will possibly corner the majority of the curren 80million per year market share of their competitors,so that can at least be good for UNIS down the road
I agree this is not new. My guess/hope is that this is nore about Biodel than UNIS. Shortall said there would be a presentation, they haven't even issued a press release from what I have seen. So I will still drink the kool-aid a little longer.
That is correct. Though it leaves me even more confused as to how UNIS calculated the $110 million revenue potential mentioned in the April 9th press release. Biodel does not seem to be a company with any viable product as of yet and is simply another drug development company burning lots of cash. In the April 9th press release, UNIS said the deal was with a pharmaceutical company. Well Biodel is a pharma company without any pharmaceuticals. Is Biodel even device savy enough to really evaluate the UNIS product?